Chemotherapy

You are here

Chemotherapy

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

Case Based Panel Discussion 2019 - Progression Post ALK Inhibitor - Role For Combination Therapies?
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda. Jonathan W. Riess, MD MS is Associate...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Chemotherapy, Radiation Therapy, Immunotherapies
Case Based Panel Discussion - 2019 ALK Positive, Progression after Success on ALK Inhibitor
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda. Jonathan W. Riess, MD MS is Associate...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Chemotherapy, Targeted Therapy
Case Based Panel Discussion - Stage 3 NSCLC Best Schedule - Durvalumab/Imfinzi in Varying Patients
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Radiation Therapy, Chemotherapy, Immunotherapies
Case Based Panel Discussion - Stage 3 NSCLC Treatment Standard and the Risk of Potential Pneumonitis
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Immunotherapies, Symptoms, Radiation Therapy, Chemotherapy
Case Based Panel Discussion Stage 3 NSCLC - Does Timing of Treatment Make a Difference in Response
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Immunotherapies, Chemotherapy, Radiation Therapy

Articles

Imprecision Medicine: Why Keytruda (Pembrolizumab) + Chemo for PD-L1+ NSCLC isn't Ready for Prime Time
Let me start by saying that I'm a fan of the immune checkpoint inhibitor Keytruda (pembrolizumab) and consider it the new standard of care as a...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
First-line treatment, Targeted Therapy, Chemotherapy, Immunotherapies
Second Line Chemotherapy Options for SCLC
Dr. Cathy Pietanza from Memorial Sloan Kettering Cancer Center discusses standard chemotherapy options for treatment of both sensitive and refractory small cell lung cancer (SCLC).
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Chemotherapy, Scans - PET-CT, etc., Symptoms
What Are Your Current Practices for Consolidation Chest Radiation for Extensive SCLC?
Drs. Leora Horn, Ben Solomon, & Jack West debate whether results from a European trial of chest radiation after chemotherapy for extensive stage small cell lung cancer should lead to a change in treatment for this setting.
Cancer Journey:
In Treatment, Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
Chemotherapy, Procedures & Treatments, Radiation Therapy
Should Immune Checkpoint Inhibitors and Other Therapies Be Combined Concurrently or Sequentially?
Drs. Leora Horn, Ben Solomon, & Jack West consider the merits of administering immune checkpoint inhibitors concurrently with standard first line chemotherapy or targeted therapy vs. sequential treatment.
Cancer Journey:
In Treatment, Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
Chemotherapy, Molecular Testing, Targeted Therapy
Is the Survival Benefit with Avastin Added to Chemotherapy Enough to Change the Standard of Care in Mesothelioma?
Drs. Ben Solomon, Leora Horn, & Jack West discuss highlights of a French randomized trial that demonstrated a significant survival benefit from addition of Avastin (bevacizumab) to cisplatin/Alimta in patients with malignant pleural mesothelioma.
Cancer Journey:
In Treatment, Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
Chemotherapy, Molecular Testing, Targeted Therapy

Community Forum

Videos now posted! OncTalk 2018 - Local Therapies for Metastatic Lung Cancer - Who, What, Why, When and How?
On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a live and webcast discussion on Local Therapies for...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer, Chemotherapy, 3rd Line and beyond, Scans - PET-CT, etc., Surgical, Immunotherapies, Radiation Therapy, Non Small Cell Lung Cancer
Adrenal metastasis from NSCLC
Greetings all, I'm a medical doctor from Vietnam. I want to discuss to you about my patient. He is 58 years old, he is hospitalize with chronic...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Chemo Medication, Chemotherapy, First-line treatment
Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?
Hi Grace Members, Grace is happy to present in partnership with the Swedish Cancer Institute " Local Therapies for Metastatic Lung Cancer Who,...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Drugs, Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1, Procedures & Treatments, Chemotherapy, Tumor Marker Tests, Targeted Therapy, Investigational Agents, Immunotherapies, Radiation Therapy, Non Small Cell Lung Cancer
Alternative medicine
My father has been dealing with prostate cancer for a couple of years now and is about to begin treatment. Does anybody have any information or...
Cancer Journey:
Cancer Type:
Disease Learning:
Chemotherapy